Clinical Trial Update: CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study

View source ↗

Summary

Clinical trial update for the CHARM study evaluating antihepadnaviral resistance mutations in chronic hepatitis B, sponsored by Gilead Sciences. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Gilead investigational anti-HBV agent

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Status: COMPLETED